Quit smoking with Champix: Parallel, randomised clinical trial of efficacy for the first time in Iran

G. Heydari, S. FallahTafti (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2012 - Tobacco cessation and tobacco cessation services
Session: Tobacco cessation and tobacco cessation services
Session type: Oral Presentation
Number: 1378

Congress or journal article abstractSlide presentation

Rating: 3
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Heydari, S. FallahTafti (Tehran, Islamic Republic Of Iran). Quit smoking with Champix: Parallel, randomised clinical trial of efficacy for the first time in Iran. Eur Respir J 2012; 40: Suppl. 56, 1378

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Training pharmacists in the stage-of-change model of smoking cessation: A randomised controlled trial in Sicily
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011

Late Breaking Abstract: Randomized, placebo-controlled trial of varenicline for smoking cessation with flexible quit dates
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010

Quit attempts and tobacco abstinence in primary care patients: follow-up of a pragmatic, two-arm cluster randomised controlled trial on brief stop-smoking advice – ABC versus 5As
Source: ERJ Open Res, 7 (3) 00224-2021; 10.1183/23120541.00224-2021
Year: 2021



Electronic cigarettes for smoking cessation: an individual patient meta-analysis of randomized controlled trials
Source: International Congress 2019 – Old and new approaches to support tobacco cessation
Year: 2019



Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo-controlled, double blind, multicenter study with 52-week follow up
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial},
Source: Eur Respir J 2012; 40: 548-554
Year: 2012



A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova
Source: Eur Respir J, 56 (2) 2000493; 10.1183/13993003.00493-2020
Year: 2020



Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



One year lung function variations in a multicenter European trial on smoking cessation (CEASE)
Source: Eur Respir J 2005; 26: Suppl. 49, 486s
Year: 2005

Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



A 12 month smoking cessation outcome-Allen Carr’s Easyway to Stop Smoking-a randomised clinical trial
Source: International Congress 2018 – Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use
Year: 2018



Randomized clinical trials with nicotine inhaler for smoking cessation
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003

Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017


No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020



Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial
Source: Eur Respir J, 58 (4) 2002819; 10.1183/13993003.02819-2020
Year: 2021



Effectiveness of a multi-component intensive smoking cessation programme for COPD outpatients: A randomized controlled trial
Source: Annual Congress 2003 - COPD and smoking (cessation)
Year: 2003


Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial
Source: Eur Respir J, 52 (4) 1800063; 10.1183/13993003.00063-2018
Year: 2018